Charles Schwab Investment Management Inc Ampio Pharmaceuticals, Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.16 - $0.47 $67,703 - $198,879	-423,148 Reduced 85.24%	73,284 $13,000
Q3 2021 Nov 16, 2021	BUY	$1.21 - $1.8 $24,046 - $35,771	19,873 Added 4.17%	496,432 $825,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $1.98 $629,109 - $798,484	403,275 Added 550.29%	476,559 $796,000
Q2 2019 Aug 09, 2019	SELL	$0.39 - $0.7 $82,414 - $147,924	-211,320 Reduced 74.25%	73,284 $29,000
Q1 2019 May 14, 2019	BUY	$0.43 - $0.68 $31,512 - $49,833	73,284 Added 34.68%	284,604 $160,000
Q4 2018 Feb 14, 2019	BUY	$0.39 - $0.7 $24,733 - $44,394	63,420 Added 42.88%	211,320 $84,000
Q2 2018 Aug 08, 2018	BUY	$1.66 - $3.82 $245,514 - $564,978	147,900 New	147,900 $326,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.